What percentage of MS doctors routinely check for latent viral reactivation in addition to bacterial infections when assessing patients whose symptoms are progressing? What factors influence doctors to perform this check or not to perform it?
What are the key deficiencies of knee-ankle-foot orthoses (KAFOs) in terms of comfort and compatibility, and how can advanced design techniques be applied to improving their usability by people with MS?
What is the effect of Biotin (vitamin B7) on improvements in fatigue for males diagnosed with progressive MS?
Why do your symptoms reduce when pregnant? Is there a treatment that can imitate so symptoms are reduced?
Do people with primary progressive MS reach a point over time where they stop experiencing new symptoms? If so, in what age range does this typically happen?
How many people on Tysabri experience a waning effect as they approach their next dose? How much does this effect impact their symptoms and quality of life?
More data/experience on ‘wearing off phenomenon’ with Ocrevus treatment. Can next infusion be administered at 5 months instead of 6 months to avoid this wearing off phenomenon?
